Rock climbing

Rock climbing has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Feb 26, 2025: “Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease”.

Intervention

1 paper studies it8 findingsUpdated

See all 1

“Findings were: CBMS (p < 0.001; ES = 0.573, 95% CI = 0.178-0.960)”
Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's diseaseArchives of physiotherapy2025doi:10.33393/aop.2025.3339

None of its findings points the other way.

  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave rock climbing to people and measured what changed.

What did studies of Rock climbing find?

4

Studies of Rock climbing measured 4 outcomes; the most studied are grip strength (1 study), manual dexterity (1) and agility (1).

Grip strength

no changein humans1

1 study
  1. Rock climbing has no effect on grip strength in humans.

    “There was no statistically significant change in GS, one of the secondary outcome measures.”

    Human trial12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

  2. Rock climbing has no effect on grip strength in humans (non-significant).

    “GS changes were non-significant.”

    Human trialmild to moderate PD (Hoehn and Yahr 1-3)twice weekly12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

Manual dexterity

upin humans1

1 study
  1. Rock climbing improves manual dexterity in humans.

    “We found small ES for three of our four secondary outcome measures [ATT, 9-Hole Peg Test (9HPT), and Reaction Time as measured by BlazePods®]; however, the Reaction Time CI includes zero, impacting our confidence in the estimate of ES on this outcome.”

    Human trial12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

  2. Rock climbing improves manual dexterity in humans (ES = 0.480, 95% CI = 0.094-0.858, p < 0.001).

    “9HPT (p < 0.001; ES = 0.480, 95% CI = 0.094-0.858)”

    Human trialmild to moderate PD (Hoehn and Yahr 1-3)twice weekly12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

Agility

upin humans1

1 study
  1. Rock climbing improves agility in humans.

    “We found small ES for three of our four secondary outcome measures [ATT, 9-Hole Peg Test (9HPT), and Reaction Time as measured by BlazePods®]; however, the Reaction Time CI includes zero, impacting our confidence in the estimate of ES on this outcome.”

    Human trial12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

  2. Rock climbing improves agility in humans (ES = 0.462, 95% CI = 0.078-0.838, p < 0.001).

    “ATT (p < 0.001; ES = 0.462, 95% CI = 0.078-0.838)”

    Human trialmild to moderate PD (Hoehn and Yahr 1-3)twice weekly12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

Balance and mobility

upin humans1

1 study
  1. Rock climbing improves balance and mobility in humans.

    “As displayed in as point estimates and 95% CIs, we found medium ES for our primary outcome measure, CBMS.”

    Human trial12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

  2. Rock climbing improves balance and mobility in humans (ES = 0.573, 95% CI = 0.178-0.960, p < 0.001).

    “Findings were: CBMS (p < 0.001; ES = 0.573, 95% CI = 0.178-0.960)”

    Human trialmild to moderate PD (Hoehn and Yahr 1-3)twice weekly12 weeksn = 28

    Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease

    Archives of physiotherapy

Latest